Market Access and HTA

Market strategy for new pharmaceutical product launches

Market Access and HTA

IQVIA provides complex market access and HTA services – from strategic planning to payer negotiations. Our experienced team provides guidance across key stages, including HTA readiness, pricing, value communication, and stakeholder engagement.

We deliver tailored solutions that reflect each product’s unique profile, align with payer expectations, and address budget impact. Our objective is to ensure sustainable patient access to innovative therapies and support their long-term integration into healthcare systems.

  • In-depth analysis: Thorough evaluation of the market, competitive landscape, and future trends. Analysis of the current and projected reimbursement status and external reference pricing across 28 EU countries.
  • Comprehensive pricing strategy: Design of optimal pricing architecture and sequencing to support successful product launch.
  • Market support: Preparation of pricing and reimbursement submissions, including risk-sharing model proposals and simulations. Active monitoring of regulatory procedures and support for payer negotiations.
Contact Us